샘플 요청 목록

 카트 문의
시장보고서
상품코드
2148426

항감염제 시장

Anti-Infectives
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 359 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,905,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 15,019,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,715,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전 항감염제 세계 시장은 2032년까지 1,632억 달러에 달할 전망

2025년 1,337억 달러로 추산되는 전 항감염제 세계 시장은 2032년까지 1,632억 달러에 달할 것으로 예상되며, 2025년부터 2032년까지의 분석 기간 동안 연평균 성장률(CAGR) 2.9%로 성장할 것으로 전망됩니다. 본 보고서에서 분석 대상으로 삼고 있는 부문 중 하나인 ‘항균제’는 연평균 성장률(CAGR) 2.1%를 기록하며, 분석 기간 종료 시점까지 642억 달러에 달할 것으로 예측됩니다. ‘항진균제’ 부문의 성장률은 분석 기간 동안 연평균 성장률(CAGR) 3.8%를 나타낼 것으로 추정됩니다.

미국 시장은 364억 달러로 추산되는 반면, 중국은 연평균 성장률(CAGR) 4.9%를 나타낼 것으로 예측됩니다.

2025년 미국의 항감염제 시장 규모는 364억 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국의 경우, 2025년부터 2032년까지의 분석 기간 동안 연평균 성장률(CAGR) 4.9%를 기록하며 2032년까지 시장 규모가 314억 달러에 달할 것으로 예측됩니다. 그 밖의 주목할 만한 지역 시장으로는 일본과 캐나다가 꼽히며, 분석 기간 동안 각각 연평균 성장률(CAGR) 1.4% 및 2.3%를 나타낼 것으로 예측됩니다. 유럽 내에서는 독일이 연평균 성장률(CAGR) 약 1.8%를 나타낼 것으로 예측됩니다.

항감염제 - 주요 동향 및 촉진요인

항감염제는 현대 의학의 초석이며, 세균, 바이러스, 진균, 기생충에 의한 감염증과 싸우기 위해 고안된 다양한 의약품으로 구성되어 있습니다. 이 광범위한 범주에는 항생제, 항바이러스제, 항진균제, 항기생충제가 포함되어 있으며, 각각은 다양한 감염증 치료에 있어 매우 중요한 역할을 수행하고 있습니다. 감염병 치료제의 개발과 사용으로 인해 발병률 및 사망률이 크게 감소했으며, 과거에는 치명적인 것으로 여겨졌던 질병의 치료에 혁명을 가져왔습니다. 지난 수십 년간 생명공학 및 제약 연구 분야의 혁신을 통해 새로운 화합물의 발견과 기존 의약품의 개량이 진행되어, 효능 향상과 부작용 감소가 이루어져 왔습니다. 항생제 내성이라는 지속적인 과제는 이 분야에서 여전히 중요한 초점이 되고 있습니다. 항생제의 과다 사용이나 오용은 약물 내성을 가진 병원균 균주의 출현을 가속화하여 공중 보건에 심각한 위협을 초래하고 있습니다. 그 결과, 내성 감염증과 싸우기 위해 새로운 항생제는 물론 박테리오파지, 단일클론 항체, 면역요법 등의 대체 요법을 발견하기 위한 연구 개발에 막대한 투자가 이루어지고 있습니다.

세계 보건 동향과 감염병 역학은 항감염제 시장에 막대한 영향을 미치고 있습니다. 코로나19를 일으키는 신종 코로나바이러스와 같은 새로운 병원체의 출현은 견고한 항감염 전략이 필수적임을 여실히 보여주었습니다. 대규모 예방접종 프로그램, 공중보건 대책, 위생 환경 개선은 감염병 억제에서 중요한 역할을 해왔습니다. 그러나 감염병의 위협이 여전히 존재하기 때문에 항감염제의 지속적인 발전이 필수적입니다. 진단 기술의 급속한 발전도 중요한 역할을 하고 있으며, 감염병을 보다 신속하고 정확하게 검출할 수 있게 해주고 있습니다. 이를 통해 적시적이고 적절한 치료가 지원되며, 감염병으로 인한 부담이 경감되고 있습니다. 또한, 세계화와 국제 여행 및 무역 증가로 인해 감염병의 국경을 초월한 전파 위험이 높아지고 있어, 충실한 감염병 치료제 비축이 필수적입니다. 첨단 감시 시스템과 국제 협력을 통한 감염 발생 감시 및 억제를 위한 노력은 시장의 역동적인 특성과 지속적인 혁신의 필요성을 더욱 부각시키고 있습니다.

항감염제 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 고처리량 스크리닝, 인공지능, 유전체 연구와 같은 신약 개발 분야의 기술적 진보로 인해 잠재적인 항감염제의 발굴이 가속화되고 있습니다. 이러한 기술을 통해 병원체를 보다 정확하게 표적화할 수 있게 되어, 약물의 효능이 향상되고 내성 발현 가능성이 낮아집니다. 암, 당뇨병, HIV 등의 만성 질환 및 면역 결핍 상태의 유병률이 높아지면서 감염증에 대한 감수성이 증가하고 있어, 효과적인 항감염 치료법에 대한 수요가 높아지고 있습니다. 소비자의 행동도 중요한 역할을 하고 있으며, 건강과 웰빙에 대한 인식 제고와 적극적인 노력이 시장 확대에 기여하고 있습니다. 신흥 시장의 헬스케어 인프라 확충과 헬스케어 서비스 접근성 개선 또한 항감염제 소비를 더욱 촉진하고 있습니다. 신속 승인이나 항생제 내성 조사에 대한 자금 지원과 같은 규제상의 인센티브가 이 시장의 성장을 뒷받침하고 있습니다. 제약 기업, 학술 기관, 정부 기관 간의 협력은 이 분야의 혁신과 개발을 촉진하며, 새롭고 효과적인 항감염제의 지속적인 공급을 보장하고 있습니다. 또한, 민관 파트너십과 세계 보건 이니셔티브는 항감염제 시장의 미충족 수요를 해결하고, 세계 감염병과 싸우기 위한 필수 의약품의 개발 및 유통을 촉진하는 데 있어 매우 중요합니다.

부문:

유형(항균제, 항진균제, 항바이러스제), 투여 경로(외용, 경구, 정맥 내 투여, 기타 투여 경로), 유통 채널(병원 약국, 소매 약국, 전문 약국, 온라인 유통 채널, 기타 유통 채널)

주요 기업

  • Allergan PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Johnson &Johnson
  • Merck &Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi

해당 분야의 전문가 관점을 바탕으로 합니다. 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착합니다 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용합니다-컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업 공시 정보, 연차 보고서, 기관지 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결합니다 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 높은 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공합니다 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 상세하게 검증합니다.

주요 지역 시장 점유율을 면밀히 검토합니다 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구도는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서에서는 각 시장의 구조와 동향에 맞춘 세부 수준으로 주요 지역 시장 점유율 분석을 전개합니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 26.10.28

Global Anti-Infectives Market to Reach US$163.2 Billion by 2032

The global market for Anti-Infectives estimated at US$133.7 Billion in the year 2025, is expected to reach US$163.2 Billion by 2032, growing at a CAGR of 2.9% over the analysis period 2025-2032. Antibacterial Type, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$64.2 Billion by the end of the analysis period. Growth in the Antifungal Type segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$36.4 Billion While China is Forecast to Grow at 4.9% CAGR

The Anti-Infectives market in the U.S. is estimated at US$36.4 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$31.4 Billion by the year 2032 trailing a CAGR of 4.9% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Anti-Infectives - Key Trends and Drivers

Anti-infectives are a cornerstone of modern medicine, comprising a diverse range of drugs designed to combat infections caused by bacteria, viruses, fungi, and parasites. This broad category includes antibiotics, antivirals, antifungals, and antiparasitics, each playing a crucial role in treating various infectious diseases. The development and use of anti-infectives have significantly reduced morbidity and mortality rates, revolutionizing the treatment of diseases that were once considered deadly. Over the past few decades, innovations in biotechnology and pharmaceutical research have led to the discovery of novel compounds and the enhancement of existing drugs, improving their efficacy and reducing side effects. The ongoing challenge of antibiotic resistance remains a significant focus within this field. The overuse and misuse of antibiotics have accelerated the emergence of drug-resistant strains of pathogens, posing a serious threat to public health. Consequently, substantial investment in research and development is directed towards discovering new antibiotics and alternative therapies, including bacteriophages, monoclonal antibodies, and immunotherapies, to combat resistant infections.

Global health trends and the epidemiology of infectious diseases heavily influence the anti-infectives market. The emergence of new pathogens, such as the novel coronavirus responsible for COVID-19, has underscored the critical need for robust anti-infective strategies. Large-scale vaccination programs, public health initiatives, and improved sanitation have played significant roles in controlling infectious diseases. However, the persistent threat of infections necessitates ongoing advancements in anti-infective drugs. Rapid progress in diagnostic technologies has also been instrumental, enabling quicker and more accurate detection of infections. This supports timely and appropriate treatment, reducing the burden of infectious diseases. Moreover, globalization, increased international travel, and trade have heightened the risk of cross-border transmission of infectious diseases, making a well-equipped arsenal of anti-infective drugs indispensable. Efforts to monitor and control outbreaks through advanced surveillance systems and international cooperation further highlight the market's dynamic nature and the need for continual innovation.

The growth in the anti-infectives market is driven by several factors. Technological advancements in drug discovery and development, such as high-throughput screening, artificial intelligence, and genomic studies, have accelerated the identification of potential anti-infective agents. These technologies allow for more precise targeting of pathogens, improving drug efficacy and reducing the likelihood of resistance development. The rising prevalence of chronic diseases and immunocompromised conditions, such as cancer, diabetes, and HIV, which increase susceptibility to infections, has heightened the demand for effective anti-infective therapies. Consumer behavior also plays a significant role, with increasing awareness and a proactive approach towards health and wellness contributing to market expansion. The expansion of healthcare infrastructure in emerging markets and improved access to healthcare services has further boosted the consumption of anti-infectives. Regulatory incentives, such as fast-track approvals and funding for antimicrobial resistance research, support the growth of this market. Collaborations between pharmaceutical companies, academic institutions, and government bodies are fostering innovation and development in the field, ensuring a continuous pipeline of new and effective anti-infective agents. Additionally, public-private partnerships and global health initiatives are crucial in addressing the unmet needs in the anti-infectives market, promoting the development and distribution of essential medicines to combat infectious diseases worldwide.

SCOPE OF STUDY:

The report analyzes the Anti-Infectives market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Antibacterial Type, Antifungal Type, Antiviral Type); Administration Route (Topical Administration Route, Oral Administration Route, Intravenous Administration Route, Other Administration Routes); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Allergan PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Anti-Infectives - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 17 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Drug-Resistant Infections Spurs Innovation
    • Technological Advancements in Drug Discovery and Development Accelerate Market Growth
    • Emergence of New Pathogens Expands Addressable Market Opportunity
    • Advances in Diagnostic Technologies Drive Adoption of Targeted Therapies
    • Globalization and Increased International Travel Throw the Spotlight on Cross-Border Transmission Risks
    • Growing Prevalence of Chronic Diseases and Immunocompromised Conditions Propels Demand
    • Regulatory Incentives and Fast-Track Approvals Sustain Growth of Anti-Infective Market
    • Public Health Initiatives and Vaccination Programs Enhances Control Measures
    • Rising Investment in Biotechnology and Pharmaceutical Research Spurs Development of Novel Compounds
    • Advancements in Nanotechnology for Drug Delivery Accelerate Demand for New Solutions
    • Impact of COVID-19 Pandemic on Anti-Infective Strategies Propels Market Awareness
    • Environmental and Ecological Changes Drive Adoption of New Anti-Infective Solutions
    • Shift Towards Sustainable and Eco-Friendly Drug Production Methods Impacts the Market
    • Demand for Multi-Functional and Combination Therapies Sustains Market Interest
    • Expansion of Telemedicine and Digital Health Platforms Drives Adoption of Anti-Infectives
    • Challenges of Antibiotic Overuse and Misuse: Here's the Story of the Growing Resistance Issue
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Anti-Infectives Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Anti-Infectives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Anti-Infectives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Anti-Infectives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Antibacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Antibacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Antibacterial Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Antifungal Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Antifungal Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Antifungal Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Antiviral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Antiviral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Antiviral Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Topical Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Topical Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Topical Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Oral Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Intravenous Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Intravenous Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Intravenous Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Specialty Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Specialty Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Specialty Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 39: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: World 13-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 42: USA Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: USA 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 44: USA Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: USA Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: USA 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 47: USA Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: USA Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: USA 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Canada Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: Canada 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Canada Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: Canada 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: Canada Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: Canada 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • JAPAN
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: Japan Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: Japan 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Japan Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: Japan 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Japan Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: Japan 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • CHINA
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: China Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: China 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 71: China Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 72: China Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: China 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 74: China Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 75: China Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: China 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • EUROPE
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Anti-Infectives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 78: Europe Historic Review for Anti-Infectives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: Europe 13-Year Perspective for Anti-Infectives by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Europe Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: Europe 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Europe Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: Europe 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Europe Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: Europe 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • FRANCE
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: France Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: France 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 92: France Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: France Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: France 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 95: France Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: France Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: France 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • GERMANY
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Germany Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Germany 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: Germany Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Germany 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Germany Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: Germany 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Italy Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: Italy 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Italy Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: Italy 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Italy Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: Italy 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: UK Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: UK 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 119: UK Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: UK Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: UK 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 122: UK Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: UK Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: UK 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Spain Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Spain 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Spain Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Spain 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Spain Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Spain 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Russia Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Russia 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Russia Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Russia 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Russia Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Russia 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Rest of Europe 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: Rest of Europe 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: Rest of Europe 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Infectives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Anti-Infectives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: Asia-Pacific 13-Year Perspective for Anti-Infectives by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: Asia-Pacific 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: Asia-Pacific 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: Asia-Pacific 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Australia Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: Australia 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Australia Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: Australia 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Australia Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: Australia 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • INDIA
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: India Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: India 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 176: India Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: India Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: India 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 179: India Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: India Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: India 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: South Korea Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: South Korea 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: South Korea Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: South Korea 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: South Korea Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: South Korea 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Anti-Infectives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 201: Latin America Historic Review for Anti-Infectives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Latin America 13-Year Perspective for Anti-Infectives by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Latin America Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Latin America 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Latin America Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Latin America 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Latin America Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Latin America 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Argentina Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Argentina 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Argentina Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Argentina 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Argentina Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Argentina 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Brazil Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: Brazil 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Brazil Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: Brazil 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Brazil Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: Brazil 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Mexico Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: Mexico 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: Mexico Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: Mexico 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: Mexico Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: Mexico 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Rest of Latin America 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Rest of Latin America 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Rest of Latin America 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Anti-Infectives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 249: Middle East Historic Review for Anti-Infectives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Middle East 13-Year Perspective for Anti-Infectives by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Middle East Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Middle East 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Middle East Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Middle East 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Middle East Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Middle East 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Iran Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Iran 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Iran Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Iran 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Iran Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Iran 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Israel Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Israel 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Israel Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: Israel 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Israel Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: Israel 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: Saudi Arabia 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: Saudi Arabia 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: Saudi Arabia 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: UAE Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: UAE 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: UAE Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: UAE 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: UAE Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: UAE 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Rest of Middle East 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Rest of Middle East 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 304: Rest of Middle East 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032
  • AFRICA
    • Anti-Infectives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 306: Africa Historic Review for Anti-Infectives by Type - Antibacterial Type, Antifungal Type and Antiviral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 307: Africa 13-Year Perspective for Anti-Infectives by Type - Percentage Breakdown of Value Sales for Antibacterial Type, Antifungal Type and Antiviral Type for the Years 2020, 2026 & 2032
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Africa Historic Review for Anti-Infectives by Administration Route - Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 310: Africa 13-Year Perspective for Anti-Infectives by Administration Route - Percentage Breakdown of Value Sales for Topical Administration Route, Oral Administration Route, Intravenous Administration Route and Other Administration Routes for the Years 2020, 2026 & 2032
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 312: Africa Historic Review for Anti-Infectives by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 313: Africa 13-Year Perspective for Anti-Infectives by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Specialty Pharmacies Distribution Channel, Online Distribution Channel and Other Distribution Channels for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기